Journal article : Comment

Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Clanchy, F. I. L. (2026). Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation. Cellular and Molecular Immunology, 23(5), 579–580.

MLA Style

Clanchy, FIL. “Mechanistic Impasses: Tofacitinib Treatment Ameliorates GM-CSF-Driven Macrophage Inflammation.” Cellular and Molecular Immunology, vol. 23, no. 5, 2026, pp. 579–80.

Chicago Style

Clanchy, FIL. 2026. “Mechanistic Impasses: Tofacitinib Treatment Ameliorates GM-CSF-Driven Macrophage Inflammation.” Cellular and Molecular Immunology 23 (5): 579–80.
Print

Access Document

Files:: Clanchy_2026_Mechanistic_impasses_tofacitinib.pdf

(Preview, Accepted manuscript, pdf, 119.6KB, Terms of use)

Publisher copy:: 10.1038/s41423-026-01406-x

Authors

+ Clanchy, FIL More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Sub department:: Kennedy Institute for Rheumatology
Role:: Author
ORCID:: 0000-0002-3629-3613

+ Epsom Medical Research More from this funder

Publisher:: Springer Nature
Journal:: Cellular and Molecular Immunology More from this journal
Volume:: 23
Issue:: 5
Pages:: 579-580
Publication date:: 2026-03-23
Acceptance date:: 2026-03-05
DOI:: 10.1038/s41423-026-01406-x
EISSN:: 2042-0226
ISSN:: 1672-7681

Language:: English
Keywords:: chronic inflammation

phagocytes
Subtype:: Comment
Pubs id:: 2431119
Local pid:: pubs:2431119
Source identifiers:: W7140078420
Deposit date:: 2026-06-08
ARK identifier:: ark:/29072/ora_ec7280ee7a5f4572a89ba469c2612909

Terms of use

Copyright holder:: Felix I. L. Clanchy
Copyright date:: 2026
Rights statement:: Copyright © 2026, The Author(s), under exclusive licence to CSI and USTC
Notes:: The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP